FoxP3 + T regulatory cells in oral lichen planus and its correlation with the distinct clinical appearance of the lesions

International Journal of Experimental Pathology

Volumn 93, Issue 4, 2012, Pages 287-294

  Pereira, Joabe S ^a   Monteiro, Bárbara V ^a   Nonaka, Cassiano F ^a   Silveira, Éricka J ^a   Miguel, Márcia C ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

FoxP3; Histomorphometry; Histopathology; Immunohistochemistry; Oral lichen planus; Regulatory T cells

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINIZATION; LICHEN PLANUS; MALE; MORPHOMETRICS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ADULT; AGED; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYPERPLASIA; INFLAMMATION; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, REGULATORY;

EID: 84864005555     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2012.00827.x     Document Type: Article

References (67)

1. Almeida A.R., Zaragoza B., Freitas A.A. (2006) Indexation as a novel mechanism of lymphocyte homeostasis: the number of CD4+CD25+ regulatory T cells is indexed to the number of IL-2-producing cells. J. Immunol. 177, 192-200.
2. Anuradha C.H., Reddy B.V., Nandan S.R., Kumar S.R. (2008) Oral lichen planus. A review. N. Y. State Dent. J. 74, 66-68.
3. Bagan Sebastian J.V., Aguirre Urizar J.M., Milián Masanet A., Peñarrocha Diago M., García Pola Vallejo M.J. (1991) [A morphometric study of 74 cases of oral lichen planus]. Rev. Stomatol. Chir. Maxillofac. 92, 265-268. [Article in French]
4. + regulatory T cells: current controversies and future perspectives. Eur. J. Immunol. 36, 2832-2836.
5. de Boer O.J., van der Loos C.M., Teeling P., van der Wal A.C., Teunissen M.B. (2007a) Immunohistochemical analysis of regulatory T cell markers FOXP3 and GITR on CD4+CD25+ T cells in normal skin and inflammatory dermatoses. J. Histochem. Cytochem. 55, 891-898.
6. de Boer O.J., van der Meer J.J., Teeling P., van der Loos C.M., van der Wal A.C. (2007b) Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS ONE 2, e779.
7. Bonelli M., von Dalwigk K., Savitskaya A., Smolen J.S., Scheinecker C. (2008) Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis. Ann. Rheum. Dis. 67, 664-671.
8. Bornstein M.M., Hakimi B., Persson G.R. (2008) Microbiological findings in subjects with asymptomatic oral lichen planus: a cross-sectional comparative study. J. Periodontol. 79, 2347-2355.
9. + regulatory T cells in transplantation. Am. J. Transplant. 9, 1719-1724.
10. Brant J.M., Vasconcelos A.C., Rodrigues L.V. (2008) Role of apoptosis in erosive and reticular oral lichen planus exhibiting variable epithelial thickness. Braz. Dent. J. 19, 179-185.
11. Chen G., Hao J., Xi Y., Wang W., Wang Z., Li N., et al. (2008) The therapeutic effect of vasoactive intestinal peptide on experimental arthritis is associated with CD4+CD25+ T regulatory cells. Scand. J. Immunol. 68, 572-578.
12. Curotto de Lafaille M.A., Lafaille J.J. (2009) Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30, 626-635.
13. Di Stefano A., Caramori G., Gnemmi I., Contoli M., Vicari C., Capelli A. (2009) T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin. Exp. Immunol. 157, 316-324.
14. Ertelt J.M., Rowe J.H., Johanns T.M., Lai J.C., McLachlan J.B., Way S.S. (2009) Selective priming and expansion of antigen-specific Foxp3- CD4+ T cells during Listeria monocytogenes infection. J. Immunol. 182, 3032-3038.
15. van Es T., van Puijvelde G.H., Foks A.C., Habets K.L., Bot I., Gilboa E., et al. (2010) Vaccination against Foxp3(+) regulatory T cells aggravates atherosclerosis. Atherosclerosis 209, 74-80.
16. Farhi D., Dupin N. (2010) Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clin. Dermatol. 28, 100-108.
17. Feng L.L., Gao J.M., Li P.P., Wang X. (2011) IL-9 Contributes to Immunosuppression Mediated by Regulatory T Cells and Mast Cells in B-Cell Non-Hodgkin's Lymphoma. J. Clin. Immunol. 31, 1084-1094.
18. + regulatory T cells: differentiation, specification, subphenotypes. Nat. Immunol. 10, 689-695.
19. Greenberg M.S., Pinto A. (2003) Etiology and Management of Recurrent Aphthous Stomatitis. Curr. Infect. Dis. Rep. 5, 194-198.
20. Grille S., Brugnini A., Nese M., Corley E., Falkenberg F.W., Lens D., et al. (2010) A B-cell lymphoma vaccine using a depot formulation of interleukin-2 induces potent antitumor immunity despite increased numbers of intratumoral regulatory T cells. Cancer Immunol. Immunother. 59, 519-527.
21. Hayashida S., Uchi H., Moroi Y., Furue M. (2011) Decrease in circulating Th17 cells correlates with increased levels of CCL17, IgE and eosinophils in atopic dermatitis. J. Dermatol. Sci. 61, 180-186.
22. Ismail S.B., Kumar S.K., Zain R.B. (2007) Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. J. Oral Sci. 49, 89-106.
23. Ito Y., Adachi Y., Makino T., Higashiyama H., Fuchizawa T., Shimizu T., et al. (2009) Expansion of FOXP3-positive CD4+CD25+ T cells associated with disease activity in atopic dermatitis. Ann. Allergy Asthma Immunol. 103, 160-165.
24. Jury E.C., Flores-Borja F., Kalsi H.S., Lazarus M., Isenberg D.A., Mauri C., et al. (2010) Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosus. Eur. J. Immunol. 40, 569-578.
25. Kalogerakou F., Albanidou-Farmaki E., Markopoulos A.K., Antoniades D.Z. (2008) Detection of T cells secreting type 1 and type 2 cytokines in the peripheral blood of patients with oral lichen planus. Hippokratia 12, 230-235.
26. Kandulski A., Wex T., Kuester D., Peitz U., Gebert I., Roessner A., et al. (2008) Naturally occurring regulatory T cells (CD4+, CD25high, FOXP3+) in the antrum and cardia are associated with higher H. pylori colonization and increased gene expression of TGF-beta1. Helicobacter 13, 295-303.
27. Karatsaidis A., Schreurs O., Helgeland K., Axéll T., Schenck K. (2003) Erythematous and reticular forms of oral lichen planus and oral lichenoid reactions differ in pathological features related to disease activity. J. Oral Pathol. Med. 32, 275-281.
28. Karube K., Ohshima K., Tsuchiya T., Yamaguchi T., Kawano R., Suzumiya J., et al. (2004) Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells. Br. J. Haematol. 126, 81-84.
29. Khattri R., Cox T., Yasayko S.A., Ramsdell F. (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4, 337-342.
30. Koreth J., Matsuoka K., Kim H.T., McDonough S.M., Bindra B., Alyea 3rd E.P., et al. (2011) Interleukin-2 and regulatory T cells in graft-versus-host disease. N. Engl. J. Med. 365, 2055-2066.
31. Kubo T., Hatton R.D., Oliver J., Liu X., Elson C.O., Weaver C.T. (2004) Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells. J. Immunol. 173, 7249-7258.
32. Lee J.H., Yu H.H., Wang L.C., Yang Y.H., Lin Y.T., Chiang B.L. (2007) The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma. Clin. Exp. Immunol. 148, 53-63.
33. Libera D.D., Mitri D.D., Bergami A., Centonze D., Gasperini C., Grasso M.G., et al. (2011) T regulatory cells are markers of disease activity in multiple sclerosis patients. PLoS ONE 6, e21386.
34. Lin S.C., Chen K.H., Lin C.H., Kuo C.C., Ling Q.D., Chan C.H. (2007) The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur. J. Clin. Invest. 37, 987-996.
35. Loddenkemper C., Hoffmann C., Stanke J., Nagorsen D., Baron U., Olek S. (2009) Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer. Cancer Sci. 100, 1112-1117.
36. Lodi G., Scully C., Carrozzo M., Griffiths M., Sugerman P.B., Thongprasom K. (2005) Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 100, 40-51.
37. López-Jornet P., Camacho-Alonso F., Molina-Miñano F. (2009) Quantitative analysis of epithelial papillae in patients with oral lichen planus. J. Eur. Acad. Dermatol. Venereol. 23, 692-696.
38. Lundgren A., Suri-Payer E., Enarsson K., Svennerholm A.M., Lundin B.S. (2003) Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect. Immun. 71, 1755-1762.
39. Masuda M., Matsumoto M., Tanaka S., Nakajima K., Yamada N., Ido N., et al. (2010) Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients. J. Neuroimmunol. 225, 123-131.
40. van der Meij E.H., van der Waal I. (2003) Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J. Oral Pathol. Med. 32, 507-512.
41. Miyara M., Sakaguchi S. (2007) Natural regulatory T cells: mechanisms of suppression. Trends Mol. Med. 13, 108-116.
42. Mu L., Sun B., Kong Q., Wang J., Wang G., Zhang S., et al. (2009) Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis. Immunology 128, e826-e836.
43. Neville B., Damm D.D., Allen C.M. (2009) [Oral and maxillofacial pathology]. 3rd edn. Rio de Janeiro (RJ): Elsevier. [in Portuguese].
44. Ou L.S., Goleva E., Hall C., Leung D.Y. (2004) T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J. Allergy Clin. Immunol. 113, 756-763.
45. Peng R.J., Huang Z.F., Zhang Y.L., Yuan Z.Y., Xia Y., Jiang W.Q., et al. (2011) Circulating and tumor-infiltrating Foxp3 regulatory T cell subset in Chinese patients with extranodal NK/T cell lymphoma. Int. J. Biol. Sci. 7, 1027-1036.
46. Scully C., Carrozzo M. (2008) Oral mucosal disease: lichen planus. Br. J. Oral Maxillofac. Surg. 46, 15-21.
47. Seoane J., Romero M.A., Varela-Centelles P., Diz-Dios P., Garcia-Pola M.J. (2004) Oral lichen planus: a clinical and morphometric study of oral lesions in relation to clinical presentation. Braz. Dent. J. 15, 9-12.
48. Skaggs B.J., Singh R.P., Hahn B.H. (2008) Induction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone mice. Hum. Immunol. 69, 790-796.
49. Sobel E.S., Brusko T.M., Butfiloski E.J., Hou W., Li S., Cuda C.M., et al. (2011) Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus. Arthritis Res. Ther. 13, R106.
50. Sojka D.K., Huang Y.H., Fowell D.J. (2008) Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target. Immunology 124, 13-22.
51. Sousa F.A., Rosa L.E. (2008) Oral lichen planus: clinical and histopathological considerations. Braz. J. Otorhinolaryngol. 74, 284-292.
52. Sousa F.A., Paradella T.C., Brandão A.A., Rosa L.E. (2009) Oral lichen planus versus epithelial dysplasia: difficulties in diagnosis. Braz. J. Otorhinolaryngol. 75, 716-720.
53. Suzuki K., Setoyama Y., Yoshimoto K., Tsuzaka K., Abe T., Takeuchi T. (2011) Decreased mRNA expression of two FOXP3 isoforms in peripheral blood mononuclear cells from patients with rheumatoid arthritis and systemic lupus erythematosus. Int. J. Immunopathol. Pharmacol. 24, 7-14.
54. Tao X.A., Xia J., Chen X.B., Wang H., Dai Y.H., Rhodus N.L., et al. (2010) FOXP3 T regulatory cells in lesions of oral lichen planus correlated with disease activity. Oral Dis. 16, 76-82.
55. Vandenbark A.A., Huan J., Agotsch M., La Tocha D., Goelz S., Offner H., et al. (2009) Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis. J. Neuroimmunol. 215, 125-128.
56. van der Waal I. (2009) Oral lichen planus and oral lichenoid lesions; a critical appraisal with emphasis on the diagnostic aspects. Med. Oral Patol. Oral Cir. Bucal 14, E310-E314.
57. Wada D.A., Wilcox R.A., Weenig R.H., Gibson L.E. (2010) Paucity of intraepidermal FoxP3-positive T cells in cutaneous T-cell lymphoma in contrast with spongiotic and lichenoid dermatitis. J. Cutan. Pathol. 37, 535-541.
58. WHO (1978) Collaborating Centre for Oral Precancerous Lesions. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg. Oral Med. Oral Pathol. 46, 518-539.
59. Wing K., Sakaguchi S. (2010) Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 11, 7-13.
60. Workman C.J., Szymczak-Workman A.L., Collison L.W., Pillai M.R., Vignali D.A. (2009) The development and function of regulatory T cells. Cell. Mol. Life Sci. 66, 2603-2622.
61. Xia J., Li C., Hong Y., Yang L., Huang Y., Cheng B. (2006) Short-term clinical evaluation of intralesional triamcinolone acetonide injection for ulcerative oral lichen planus. J. Oral Pathol. Med. 35, 327-331.
62. Xie Y., Wu M., Song R., Ma J., Shi Y., Qin W., et al. (2009) A glucocorticoid amplifies IL-2-induced selective expansion of CD4(+)CD25(+)FOXP3(+) regulatory T cells in vivo and suppresses graft-versus-host disease after allogeneic lymphocyte transplantation. Acta Biochim. Biophys. Sin. 41, 781-791.
63. Yan B., Liu Y. (2009) The Nature of Increased Circulating CD4CD25Foxp3 T Cells in Patients with Systemic Lupus Erythematosus: a Novel Hypothesis. Open Rheumatol. J. 3, 22-24.
64. Yan B., Ye S., Chen G., Kuang M., Shen N., Chen S. (2008) Dysfunctional CD4+, CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis Rheum. 58, 801-812.
65. Yang J., Chu Y., Yang X., Gao D., Zhu L., Yang X., et al. (2009) Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum. 60, 1472-1483.
66. Zhang B., Zhang X., Tang F.L., Zhu L.P., Liu Y., Lipsky P.E. (2008) Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus. Ann. Rheum. Dis. 67, 1037-1040.
67. Zhao Z., Wu Y., Cheng M., Ji Y., Yang X., Liu P., et al. (2011) Activation of Th17/Th1 and Th1, but not Th17, is associated with the acute cardiac event in patients with acute coronary syndrome. Atherosclerosis 217, 518-524.